Asthma: effect of excess short-acting β2-agonist (SABA) inhaler prescriptions on healthcare resource utilisation

Br J Gen Pract. 2024 Jul 25;74(745):374-376. doi: 10.3399/bjgp24X739089. Print 2024 Aug.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Inhalation
  • Adrenergic beta-2 Receptor Agonists* / therapeutic use
  • Adult
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma* / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nebulizers and Vaporizers*
  • Patient Acceptance of Health Care / statistics & numerical data
  • Practice Patterns, Physicians' / statistics & numerical data

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Anti-Asthmatic Agents